Boston, MA
Oct 21- Oct 24, 2022

The conference is designed to integrate multi-disciplinary facets of basic cancer immunology and immunotherapy to broaden our understanding of ways to harness the immune system to treat cancer. The hallmark of this series is also to encourage the effective exchange of ideas between basic cancer immunologists, non-immunologists, and clinical oncologists in order to develop approaches that translate to outcomes. This year’s program will feature international leaders in the field, who will expand our knowledge of the microbiome, alternative checkpoints beyond PD-1 and CTLA-4, imaging and other new technologies, adoptive T cell therapy with a focus on challenges in solid tumors, and myeloid cells in the tumor microenvironment.

Boston, MA and virtual
Nov 8- Nov 12, 2022

Registrants who select to attend Annual Meeting and/or Pre-Conference Programs in person can participate in the onsite meeting and will be granted access to the virtual enduring materials for the selected program(s). Attendees who participate in-person have access to onsite networking opportunities, poster hall and exhibit hall. The virtual meeting platform, including live-streamed content, virtual networking, ePoster hall and virtual exhibits, is available to all registrants for their selected program(s).

Registrants who select to attend the Annual Meeting and/or Pre-Conference Programs virtually will receive real-time access and enduring materials for their selected program(s) using a virtual meeting platform. Attendees who participate virtually will have access to live-streamed presentations with the ability to participate in live Q&A for program(s) for which they have registered. The virtual meeting platform includes virtual networking opportunities, an ePoster hall and virtual exhibits.

Additional programs purchased by in-person attendees can be virtual or in person.

Montreal, Québec
Nov 19- Nov 21, 2022

We're pleased to announce the 2022 Summit4CI will be held in-person in Montréal, Québec. We hope you'll join us November 19-21, 2022, at the Fairmont The Queen Elizabeth Hotel. Mark your calendar!

Nov 22- Nov 23, 2022

The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments in immune oncology. This year’s focus will be on tumor microenvironment, cell-based therapy in hematology and oncology, precision medicine addressing tolerance and inflammation, immune checkpoint inhibitors, biomarkers, and cancer vaccines. You are invited to submit an abstract of your scientific work to be presented virtually as a poster at LION 2022.

The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Cancer Center of the University Hospital Leipzig, both located in Leipzig, Germany. We are looking forward to welcoming you virtually at LION 2022 on November 22-23, 2022.

Austin, TX and virtual
Jan 17- Jan 21, 2023

Through this hybrid program attendees will have access to the best in cancer immunotherapy education taught by leading experts in the field. This program will provide a deep understanding of the core principles of tumor immunology and cancer immunotherapy as well as develop areas in the field including biomarker technology, validation and clinical integration; clinical trial design, data analysis and considerations for combination therapies.

San Diego, CA
Nov 1- Nov 5, 2023


Close Modal

Small change for you. Big change for us!

This Thanksgiving season, show your support for cancer research by donating your change.

In less than a minute, link your credit card with our partner RoundUp App.

Every purchase you make with that card will be rounded up and the change will be donated to ACIR.

All transactions are securely made through Stripe.